| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $368.7M | — | +3.8% |
| Cost of Revenue | $262.3M | — | +6.9% |
| Gross Profit | $106.4M | — | -3.0% |
| R&D Expense | $18.5M | — | +8.3% |
| SG&A Expense | $38.6M | — | +3.5% |
| Operating Income | $6.0M | — | +102.4% |
| Interest Expense | $11.9M | — | -7.7% |
| Pre-tax Income | -$15.6M | — | +94.1% |
| Income Tax | -$614K | — | +83.1% |
| Net Income | -$15.0M | — | +94.2% |
| EPS (Basic) | -$0.36 | — | +94.2% |
| EPS (Diluted) | -$0.36 | — | +94.2% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $209.1M | +9.6% | +17.6% |
| Inventory | $375.1M | -3.5% | -8.2% |
| Current Assets | $764.3M | +2.5% | +7.0% |
| Total Assets | $1.66B | -0.6% | -14.3% |
| Current Liabilities | $255.9M | -1.7% | +14.0% |
| Long-term Debt | $512.2M | -2.2% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.1M | — | -2461.9% |
| Capital Expenditures | $5.4M | — | -24.9% |
| Investing Cash Flow | -$426K | — | +94.1% |
| Financing Cash Flow | $13.1M | — | +291.3% |
| Free Cash Flow | -$21.5M | — | -230.0% |
| -6.3% |
| Total Liabilities | $1.00B | +0.1% | +0.5% |
| Stockholders' Equity | $658.8M | -1.7% | -29.9% |